DR-TB Drugs Under the Microscope, 4th edition
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.
Additional publications in the DR-TB Drugs Under the Microscope report series are available here.
Learn more about MSF’s work to improve access to lifesaving TB treatment.